Dual infection with Neisseria gonorrhoeae and Chlamydia trachomatis.
Moss
T R
TR
Van Der Pol
B
B
D000038:Abscess / Q000188:drug therapy / Q000209:etiology / Q000382:microbiology; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002690:Chlamydia Infections / Q000150:complications* / Q000188:drug therapy / Q000382:microbiology; D002692:Chlamydia trachomatis / Q000235:genetics / Q000302:isolation & purification; D004359:Drug Therapy, Combination; D009877:Endophthalmitis / Q000150:complications / Q000188:drug therapy / Q000382:microbiology; D005260:Female; D006069:Gonorrhea / Q000150:complications* / Q000188:drug therapy / Q000382:microbiology; D006801:Humans; D008297:Male; D009344:Neisseria gonorrhoeae / Q000235:genetics / Q000302:isolation & purification; D034161:Pelvic Infection / Q000150:complications / Q000188:drug therapy / Q000382:microbiology; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents